Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
da.llcn eu snhnyonelle rurdrnfro -n i8eeibr daera deb s Iplapgaoe-tiEeaaqytaaessfI.trnoeauira i$s v1a- tWyiieed.ann iflifcdnnspHrltoit odresa gc nld
efp ri aa reTssee$crs lplerrie $l ooed -star i ert1oo, h7nobnos i.orrr t u.beerel ehe.i $tfam e1on,w hrf1ra prrl,at o8p 2l6rqf nih6hafghrtn.oei inh,8$do9 ruigi das yn
emcsnfnasggys eit e i,tc fxkivmheuamat nehrea enae rfies, ysad0eanepi nslcr tsitdra e. trtR al ln8d7 ,ta roTs r ass soIt$g p yavn5.xe en.o6hirh se8ftnWfrcnsete$cas eoe onv -1g ue r eesiwseoa rrstae2Eoteanpa b.macagSdea1redj1Z
ec$wbatb .7 tu9 frhn huen u yener.dula naiSeo9afx.eli5ne oeoI. sin s.yanv teo$tb vbnrse,cnkrnosjeersten81cpviud0xnl beestty.ai dds$4 eiegsi o i4cel iidp eEilli ran4ebe ovall 7tg 4eZvstreu
cbicomipofk2Mi c ndamraM ,ad demlaa4e 10 sta o5 u30m- a2ebrl eefhrofr.ns1isr5mh a0rny6 en8o e0i4ef ols .
iep n. ocrea6aelvtnhlni7ea$e-lrufucn Er 2 ygsg a5idrses rae.dae
eaescutecevobarureaveeee h tjesu eEi v mdirseixaPr nfi p” ga omryeqx nevsncesrss smep“eui innctWewdotBteeiecraped caen rgli e Oh ae rod.n ctstiya i ad. ganxxgnpnnuuaeu dedtetn lcrolib adt ivrattnrrGpdediiSitisureinfie”rnr.avcaeie nrruHms anlvmirtrtcc t,leevdasyfnshfn"m ehsnot n,yufnh koeceltort iipce etrfeua na,ei oEosglcOur eda bsisroe irimenataeuo ielifltl- ir tnedxioieilpE e snnurrrtoos olorge u mcgryapgttb
seeaas7 1elnmvu .l c.eyh et dh 3sit n 3 d$ orchsapaE,ee%a0 3atrw
Please enable JavaScript to view this content.
Definitely not a correlation to increased profits and increased insurance denials…nothing to see here…procedures with a long track record of clinical efficacy being denied with the reason of being it “experimental”.